New hope for rare joint tumor: drug shrinks growths without surgery
NCT ID NCT04488822
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 32 times
Summary
This study tests a drug called pexidartinib in 40 adults with a rare joint tumor (TGCT) that causes severe symptoms and cannot be helped by surgery. The main goal is to see if the drug shrinks the tumors after 25 weeks of treatment. Participants take the drug daily and are monitored for safety and tumor response using MRI scans.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TENOSYNOVIAL GIANT CELL TUMOR are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Beijing Ji Shui Tan Hospital
Beijing, China
-
Fudan University Shanghai Cancer Center
Shanghai, China
-
National Taiwan University Hospital
Taipei, Taiwan
-
Peking University Cancer Hospital
Beijing, China
-
Shanghai General Hospital
Shanghai, China
-
Taipei Veterans General Hospital
Taipei, Taiwan
-
The First Affiliated Hospital, Sun Yat-sen University
Guangzhou, China
-
The Second Affiliated Hospital of Zhejiang University School of Medicine
Hangzhou, China
-
Zhejiang Cancer Hospital
Hangzhou, China
Conditions
Explore the condition pages connected to this study.